Compare Brevis (BREV) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Enzyme — how do they compare? Brevis trades at Rp1,329 (market cap Rp331,92M, Rp229,7M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Brevis is far larger — about 2.5× Enzyme's market cap, and Brevis's supply is capped (250M / 1B BREV (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Enzyme for 28 Days on average.
| BREV | MLN | |
|---|---|---|
Market Cap | Rp331,92M | Rp134,13M |
Volume (24h) | Rp229,7M | Rp104,56M |
Circulating Supply | 250M / 1B BREV (25%) | 3,3M MLN |
Typical Hold Time | 6 Days | 28 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
